Fetus treated with risdiplam for rare genetic disorder, a medical first
HQ Team February 27, 2025: A study published in The New England Journal of Medicine (NEJM) reveals that administration of the oral drug.
Drugs
Health
Drugs
Health
Pharma
Novartis to pay $100m upfront to Voyager for gene therapies
HQ Team January 3, 2023: Voyager Therapeutics, Inc., will receive an upfront payment of $100 million from Switzerland-based Novartis AG to develop gene.